Version 2.0 of colon cancer diagnostic will reportedly require fewer steps and be faster and easier to automate. Life Technologies is to supply Epigenomics with its Dynabeads® MyOne™ Silane and ...
– Data Presented at DDW 2019 Show 93.6% Acceptance Rate Among Patients Unwilling or Unable to Complete Other CRC Screening Tests – BERLIN and SAN DIEGO, May 19, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG ...
Epigenomics: Epi Procolon included in newly issued USPSTF guidelines for colorectal cancer screening
* USPSTF guidelines expected to support adoption of Epi Procolon by patients, physicians and insurers Source text for Eikon: Further company coverage: ...
Blood-based colorectal cancer screening test Epi proColon was more cost-effective than other alternative screening options, according to a company release about a study published in the Journal of the ...
Company also has a lung cancer test in development. Epigenomics confirmed the European launch of Epi proColon, reportedly the first CE-marked IVD blood test for detecting colorectal cancer. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results